Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 24 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

24 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
April 14, 2022 BHC S 10b5-1 1,595 $22.19 $35,393 90,506 Direct -1.73% Disposed -73.9% (price as of 2026-10-02)
March 15, 2022 BHC S 10b5-1 4,846 $22.20 $107,581 92,101 Direct -5.00% Disposed -73.9% (price as of 2026-10-02)
March 2, 2022 BHC S 10b5-1 1,595 $23.37 $37,275 65,394 Direct -2.38% Disposed -75.2% (price as of 2026-10-02)
Feb. 15, 2022 BHC S 10b5-1 3,251 $25.02 $81,340 60,299 Direct -5.12% Disposed -76.8% (price as of 2026-10-02)
Jan. 18, 2022 BHC S 10b5-1 3,251 $26.63 $86,574 63,550 Direct -4.87% Disposed -78.2% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) · May 10, 2022 13,592 Disposed
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (13,592) · May 10, 2022 13,592 Acquired
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) · May 10, 2022 8,643 Disposed
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (8,643) · May 10, 2022 8,643 Acquired
March 2, 2022 BHC Non-Qualified Stock Options (right to purchase) Common Shares, No Par Value (131,910) $24.17 March 2, 2032 131,910 Acquired
Feb. 27, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) $24.35 Feb. 27, 2022 15,615 Disposed
Feb. 27, 2022 BHC Restricted Share Units Common Shares, No Par Value (15,615) · Feb. 27, 2022 15,615 Acquired
Sept. 1, 2021 BHC Non-Qualified Stock Options (right to purchase) Common Shares, No Par Value (31,400) $28.85 Sept. 1, 2031 31,400 Acquired
March 3, 2021 BHC Non-qualified Stock Options (right To Purchase) Common Shares, No Par Value (32,749) $32.56 March 3, 2031 32,749 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 1, 2020 BHC Common Shares, No Par Value · Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (30,576) 30,576 Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (39,863) 39,863 Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (56,858) 56,858 Direct
March 12, 2012 RGEN Common Stock 10,000 Direct
March 12, 2012 RGEN Stock Option (Right to Purchase)→ Common Stock (100,000) 100,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BHC

President US Pharmaceutical Business
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $336,538 · $861,105 $874,563 · · $2,230,891 $4,303,097
2021 $636,154 · · · $821,200 · $18,050 $3,868,624

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.